We are live on ! Find out more
ALNA

Allena Pharmaceuticals
ALNA

Delisted

ALNA was delisted on the 7th of September, 2022.

Back to rankings

46 hedge funds and large institutions have $62.4M invested in Allena Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 15 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 12

6% less funds holding

Funds holding: 49 → 46 (-3)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

46% less capital invested

Capital invested by funds: $116M → $62.4M (-$54M)

47% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 15

Holders
46
Holders Change
-3
Holders Change %
-6.12%
% of All Funds
1%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
11
Increased
8
Reduced
15
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$1.78M
2
Renaissance Technologies
Renaissance Technologies
New York
+$335K
3
SFM
Sphera Funds Management
Israel
+$328K
4
Goldman Sachs
Goldman Sachs
New York
+$318K
5
PP
Paloma Partners
Connecticut
+$285K

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$3.68M
2
BlackRock
BlackRock
New York
-$2.69M
3
State Street
State Street
Massachusetts
-$1.27M
4
JP Morgan Chase
JP Morgan Chase
New York
-$941K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$292K
Name Holding Trade Value Shares
Change 		Change in
Stake
Acadian Asset Management
51
Acadian Asset Management
Massachusetts
– -$106K -15,070 Closed
RhumbLine Advisers
52
RhumbLine Advisers
Massachusetts
– -$99K -14,059 Closed
New York State Common Retirement Fund
53
New York State Common Retirement Fund
New York
– -$73K -10,400 Closed
AIG
54
American International Group
New York
– -$52K -7,394 Closed
SO
55
STRS Ohio
Ohio
– -$10K -1,500 Closed
AIP
56
Ameritas Investment Partners
Nebraska
– -$3K -460 Closed
Bank of Montreal
57
Bank of Montreal
Ontario, Canada
– +$71 +13 New
UBS Group
58
UBS Group
Switzerland
– +$148 +27 New
1 2
3

ALNA Hedge Fund Activity: Q2 2019 in Review

46 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Allena Pharmaceuticals (ALNA) for Q2 2019, worth a combined $62.4M — down 46% from $116M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of ALNA and 11 opened new positions — a net loss of 1 holder — while 15 trimmed existing stakes and 8 added.

The largest buyer was Millennium Management, opening a new position worth an estimated $1.78M. The largest seller was PFM Health Sciences, cutting an estimated $3.68M.

  • 46 institutional investors held Allena Pharmaceuticals (ALNA) as of Q2 2019, down from 49 in Q1 2019.
  • Funds reported $62.4M of Allena Pharmaceuticals stock for Q2 2019, down 46% quarter-over-quarter.
  • 11 funds opened new Allena Pharmaceuticals positions in Q2 2019 and 12 closed out, a net change of -1 holder.
  • The largest Allena Pharmaceuticals buyer in Q2 2019 was Millennium Management, an estimated $1.78M added.
  • The largest Allena Pharmaceuticals seller in Q2 2019 was PFM Health Sciences, an estimated $3.68M sold.

Based on aggregated 13F filings for Q2 2019.